| Members |
targetComponentId |
| Atmospheric control NOS |
Respiratory therapy by atmospheric control |
| Atmospheric control NOS |
Respiratory therapy by atmospheric control |
| Atonic epilepsy |
A disease of the brain characterized by an enduring predisposition to generate epileptic seizures. |
| Atopic eczema/dermatitis NOS |
Atopic dermatitis (disorder) |
| Atopic eczema/dermatitis NOS |
Atopic dermatitis (disorder) |
| Atorvastatin calcium 10mg tablet |
Atorvastatin (as atorvastatin calcium) 10 mg oral tablet |
| Atorvastatin calcium 20mg tablet |
Atorvastatin (as atorvastatin calcium) 20 mg oral tablet |
| Atorvastatin calcium 40mg tablet |
Atorvastatin (as atorvastatin calcium) 40 mg oral tablet |
| atosiban 7,5 mg/ml koncentrat til infusionsvæske, hætteglas a 5 ml |
Product containing precisely atosiban (as atosiban acetate) 7.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Atovaquone+proguanil hydrochloride |
Product containing atovaquone and proguanil (medicinal product) |
| atracuriumbesylat 100 mg/10 ml opløsning |
Atracurium besilate 10 mg/mL solution for injection |
| Atrialt myksom med lentigines |
A rare endocrine disease characterized by lentigines with a specific peri-orifical distribution, blue nevus, myxomas, various endocrine tumors including primary pigmented nodular adrenocortical disease (PPNAD), acromegaly, thyroid tumors, and a wide range of other tumors. |
| Atrioventrikulært blok, ikke nærmere specificeret |
Atrioventricular block |
| Atrioventrikulært blok, uspecificeret |
Atrioventricular block |
| Atrophic age-related macular degeneration |
Nonexudative age-related macular degeneration (disorder) |
| atropin 2,1 mg + pralidoxim 600 mg, opløsning, enkelt autoinjektor |
Product containing only atropine and pralidoxime in parenteral dose form (medicinal product form) |
| Atropine sulfate + edrophonium chloride 0.14mg/10mg injection |
Product containing only atropine and edrophonium (medicinal product) |
| atropinsulfat 0,031 % øjendråber |
Product containing precisely atropine sulfate 310 microgram/1 milliliter conventional release eye solution (clinical drug) |
| atropinsulfat 0,062 % øjendråber |
Atropine sulfate 620 microgram/mL eye solution |
| atropinsulfat 0,1 % øjendråber |
Atropine sulfate 1 mg/mL eye solution |
| atropinsulfat 0,25 % øjendråber |
Product containing precisely atropine sulfate 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
| atropinsulfat 140 µg + edrophoniumchlorid 10 mg injektionsvæske til opløsning, hætteglas |
Product containing only atropine and edrophonium (medicinal product) |
| Atropine sulfate 500micrograms/5mL conventional release oral solution |
Atropine only product in oral dose form |
| atropinsulfat 500 µg/5 ml sukkerfri opløsning |
Atropine only product in oral dose form |
| Fastgørelse af lapgraft til ekstremitet |
Reconstruction of extremity using flap |
| Attachment of flap graft to hand |
Reconstruction of hand using flap (procedure) |
| Attachment of groin flap graft to hand |
Reconstruction of hand using distant groin flap (procedure) |
| Attachment of pedicle flap graft |
Reconstruction using skin flap |
| Fastgørelse af stilket hudlap-graft |
Reconstruction using skin flap |
| Attempted suicide NOS |
Suicide attempt |
| Attempted suicide NOS |
Suicide attempt |
| Attend allowance exam NOS: [DS4] or [DS1500] |
Attendance allowance medical (procedure) |
| Attend allowance exam NOS: [DS4] or [DS1500] |
Attendance allowance medical (procedure) |
| Attention to cerebroventricular shunt NEC |
Attention to cerebroventricular shunt |
| Attention to component of connection from ventricle of brain NOS |
Attention to component of connection from ventricle of brain (procedure) |
| Attention to graft of organ NOC |
Attention to device (procedure) |
| kontrol af delvist cementeret total knæalloplastik, ikke klassificeret andetsteds |
Attention to hybrid total knee replacement |
| Attention to microvascular repair of organ NOC |
Attention to anastomosis |
| Attention to prosthesis NOC |
Attention to device (procedure) |
| Attention to prosthesis NOC NOS |
Attention to device (procedure) |
| Attention to prosthesis NOC OS |
Attention to device (procedure) |
| Attention to prosthesis of aorta NOS |
Attention to prosthesis of aorta |
| kontrol af total hoftealloplastik, ikke klassificeret andetsteds |
Attention to total hip replacement |
| kontrol og vedligeholdelse af total knæalloplastik, ikke klassificeret andetsteds |
Attention to total knee replacement (procedure) |
| Atypical absence epilepsy |
An absence seizure with changes in tone that are more pronounced than in a typical absence seizure or the onset and/or cessation is not abrupt, often associated with slow (less than three per second), irregular, generalized spike-wave activity. |
| Atypisk antipsykotisk middel |
Anti-psychotic agent (substance) |
| Auditory function |
Hearing |
| augmentation af alveolarproces, ikke klassificeret andetsteds |
Augmentation of alveolar ridge |
| patients tante |
Aunt |
| Aurantimonas altamirensis |
Aureimonas altamirensis (organism) |
| Aureobacterium |
Microbacterium |
| Aureobacterium saperdae |
Microbacterium saperdae (organism) |
| Aureobacterium species |
Microbacterium |
| Auricular flap |
Flap (substance) |
| Auriculoocular anomaly and cleft lip syndrome |
A rare genetic multiple congenital anomalies/dysmorphic syndrome characterized by the association of auricular abnormalities (such as external ear abnormalities and postauricular pits) and cleft lip with or without cleft palate. Additional manifestations include myopia, nystagmus, and retinal pigment abnormalities. |
| Author/writer/journalist NOS |
Author, journalist AND/OR related writer |
| Author/writer/journalist NOS |
Author, journalist AND/OR related writer |
| Autism and facial port-wine stain syndrome |
Sturge-Weber syndrome |
| Autistic disorder |
Pervasive developmental disorder (disorder) |
| Autisme |
Pervasive developmental disorder (disorder) |
| transplantation af autolog vaskulariseret knoglegraft |
Autogenous vascularised bone |
| Autograft |
Autograft |
| Autograft to organ NOC |
A procedure where a subject receives a transplant of their own organ, tissue, or cells. |
| Autoimplant |
Autoimplant |
| autointoksikation |
Intestinal dysbiosis |
| Automobile mechanic |
Motor vehicle mechanic |
| Automotive battery fluid causing toxic effect |
Toxic effect of sulfuric acid |
| Autoreplacement of organ NOC |
A procedure where a subject receives a transplant of their own organ, tissue, or cells. |
| Autosomal dominant limb girdle muscular dystrophy type 1B |
Autosomal dominant Emery-Dreifuss muscular dystrophy (disorder) |
| Autosomal dominant limb girdle muscular dystrophy type 1C |
Rippling muscle disease (disorder) |
| Autosomal dominant okulokutan albinisme |
Piebaldism is a rare congenital pigmentation skin disorder characterized by the presence of hypopigmented and depigmented skin areas (leukoderma) on various parts of the body, preferentially on the forehead, chest, abdomen, upper arms, and lower extremities, that are associated with a white forelock (poliosis), and in some cases with hypopigmented and depigmented eyebrows and eyelashes. |
| Autosomal recessive limb girdle muscular dystrophy type 2R |
A rare genetic skeletal muscle disease characterized by abnormal chimeric aggregates of desmin and other cytoskeletal proteins and granulofilamentous material at the ultrastructural level in muscle biopsies and variable clinical myopathological features, age of disease onset and rate of disease progression. Patients present with bilateral skeletal muscle weakness that starts in distal leg muscles and spreads proximally, sometimes involving trunk, neck flexors and facial muscles and often cardiomyopathy manifested by conduction blocks, arrhythmias, chronic heart failure, and sometimes tachyarrhythmia. Weakness eventually leads to wheelchair dependence. Respiratory insufficiency can be a major cause of disability and death, beginning with nocturnal hypoventilation with oxygen desaturation and progressing to daytime respiratory failure. |
| Aversion therapy NOS |
Aversive psychotherapy |
| Aversion therapy NOS |
Aversive psychotherapy |
| aviært adenovirus gruppe II |
Turkey adenovirus A (organism) |
| aviært adenovirus gruppe III |
Duck adenovirus 1 (organism) |
| Avian astrovirus |
Genus Avastrovirus (organism) |
| Avian paramyxovirus |
Genus Avulavirus (organism) |
| Avian reovirus |
Avian orthoreovirus |
| avobenzon 2 % + ecamsul 2 % + octocrylen 10 % creme til topikal anvendelse |
Product containing only avobenzone and ecamsule and octocrilene (medicinal product) |
| Avobenzone 2%/ecamsule 2%/octocrilene 10%/titanium dioxide 2% topical cream |
Product containing only avobenzone and ecamsule and octocrilene and titanium dioxide (medicinal product) |
| avobenzon 2 % + ecamsul 3 % + octocrylen 10 % creme til topikal anvendelse |
Product containing only avobenzone and ecamsule and octocrilene (medicinal product) |
| Avobenzone 2%/ecamsule 3%/octocrilene 10%/titanium dioxide 5% topical cream |
Product containing only avobenzone and ecamsule and octocrilene and titanium dioxide (medicinal product) |
| Avocado - dietary |
Avocado (substance) |
| avulsion af nervus alveolaris inferior ved osteotomi |
Avulsion of inferior alveolar nerve due to osteotomy (disorder) |
| Avulsion of tooth |
Complete avulsion of tooth (disorder) |
| Awaiting housing NOS |
Finding relating to awaiting housing or re-housing |
| Awaiting housing NOS |
Finding relating to awaiting housing or re-housing |
| Axillary axial pattern flap |
Axial pattern flap |
| aksillær linje i abdomen |
Anterior axillary line of abdomen |
| azatadinmaleat 1 mg + pseudoephedrinsulfat 120 mg tablet med modificeret udløsning |
Azatadine and pseudoephedrine only product in oral dose form |
| Azatadine maleate+pseudoephedrine sulfate 1mg/120mg prolonged-release oral tablet |
Azatadine and pseudoephedrine only product in oral dose form |
| azithromycin 1 % opløsning til oftalmisk anvendelse |
Azithromycin 10 mg/mL eye drops |
| Azithromycin 100mg/5mL oral suspension |
Product containing precisely azithromycin 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Azithromycin 250mg tablet |
Product containing precisely azithromycin 250 milligram/1 each conventional release oral tablet (clinical drug) |
| azithromycin 2 g/60 ml mikrosfærer oral suspension |
Product containing precisely azithromycin 33.3 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Azithromycin 600mg tablet |
Product containing precisely azithromycin 600 milligram/1 each conventional release oral tablet (clinical drug) |
| azithromycindihydrat 100 mg/5 ml suspension |
Product containing precisely azithromycin 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Azithromycin dihydrate 250mg capsule |
Product containing precisely azithromycin 250 milligram/1 each conventional release oral tablet (clinical drug) |
| Aztreonam 75mg powder for nebulizer solution |
Product containing precisely aztreonam 75 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
| B lymphoblastic leukemia / lymphoma - category |
B lymphoblastic leukaemia lymphoma |
FHIR